Eliminating hepatitis by 2030: HHS releases new strategic plan
January 14, 2021
The United States “is currently facing unprecedented hepatitis A outbreaks, while progress in preventing hepatitis B has stalled, and hepatitis C rates nearly tripled.”
Updated USPSTF HBV screening recommendation may be a ‘lost opportunity’
January 12, 2021
The recommendation defines risk groups more narrowly than the CDC, AASLD, and some research suggests risk-based screening is ineffective for chronic conditions.
Liver injury linked to COVID-19–related coagulopathy
November 18, 2020
Cells that line the liver’s blood vessels produce high levels of factor VIII, a coagulation factor, when they are exposed to interleukin-6, an inflammatory molecule associated with COVID-19.
INR fails to predict bleeding in patients with cirrhosis
October 6, 2020
The investigators hope the study findings reinforce minimizing administration of fresh frozen plasma for inappropriate correction of international normalized ratio, which carries a multitude of adverse effects among cirrhotic patients.
Tools emerging to predict liver failure in cirrhosis
September 9, 2020
Systemic inflammation, with high levels of proteins, is one of the mechanisms that leads to organ failure.
NAFLD may predict arrhythmia recurrence post-AFib ablation
August 14, 2020
The presence of nonalcoholic fatty liver disease adds a further modifiable target for preablation medical optimization, researchers say.
New CDC guidance for health care personnel exposed to HCV
July 24, 2020
Baseline testing of the source patient and the HCP should be performed as soon as possible, preferably within 48 hours of exposure.
CDC: Screen nearly all adults, including pregnant women, for HCV
April 10, 2020
Screening should go beyond baby boomers.
What’s new in hepatitis C: Four themes that dominated at the Liver Meeting
November 22, 2019
BOSTON – AASLD highlights included treatment of persons who inject drugs, new directions in pangenotypic therapy, benefits of sustained virologic response, preemptive therapy in donor-positive organ transplant.
Type of renal dysfunction affects liver cirrhosis mortality risk
September 4, 2019
Patients with acute on chronic kidney disease fared the worst.